e-learning
resources
Virtual 2020
Pre-Congress Content
Personalised treatment of obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identifying subgroups of asthma patients for potential intervention using electronic medication monitors (EMM)
R. Gondalia (San Francisco, United States of America), L. Kaye (San Francisco, United States of America), D. Van Sickle (Madison, United States of America), D. Stempel (San Francisco, United States of America), M. Barrett (San Francisco, United States of America)
Source:
Virtual Congress 2020 – Personalised treatment of obstructive diseases
Session:
Personalised treatment of obstructive diseases
Session type:
E-poster session
Number:
2668
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Gondalia (San Francisco, United States of America), L. Kaye (San Francisco, United States of America), D. Van Sickle (Madison, United States of America), D. Stempel (San Francisco, United States of America), M. Barrett (San Francisco, United States of America). Identifying subgroups of asthma patients for potential intervention using electronic medication monitors (EMM). 2668
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Assessing the utility of asthma medication monitoring sensors in a group of high risk asthmatic children
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017
Clinical outcome of nutritional intervention integrated in an
INTER
disciplinary
COM
munity-based COPD lifestyle program (INTERCOM) in moderate COPD
Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing
Year: 2008
Evidence that children can assess their asthma medication devices
Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions
Year: 2011
Characteristics of effective self-management interventions in patients with COPD: individual patient data meta-analysis
Source: Eur Respir J 2016; 48: 55-68
Year: 2016
Effectiveness of an educational intervention in order to improve adherence in COPD and asthma ambulatory patients.
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
Facilitators and barriers of adherence to exacerbation action plans in patients with COPD and comorbidities: a qualitative study
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β
2
-agonist (LABA) therapy: results from the UK general practice research database (GPRD)
Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care
Year: 2009
Adherence to medication advice through a remote electronic asthma and COPD service
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021
Efficacy of long-term educational program (EP) of patients with COPD
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010
Real-world patient characteristics and eligibility for biologics in severe asthma (RECOGNISE)
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting ß
2
-agonist use in asthma
Source: Eur Respir J, 55 (2) 1901858; 10.1183/13993003.01858-2019
Year: 2020
Engagement with an asthma app to monitor medication adherence and its association with patients’ characteristics
Source: Virtual Congress 2021 – Remote monitoring of respiratory patients
Year: 2021
Development and evaluation of an educational intervention targeted at optimising adherence with measures to prevent asthma in children with a familial allergic disposition (FOCUS-project)
Source: Eur Respir J 2002; 20: Suppl. 38, 329s
Year: 2002
QVA149 provides significant symptomatic benefit to COPD patients as measured by a new symptom e-diary: The SHINE study
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children
Source: Eur Respir J, 50 (6) 1700910; 10.1183/13993003.00910-2017
Year: 2017
Identifying inconsistencies in intervention descriptors and outcome reporting within systematic reviews of physical activity interventions in COPD
Source: International Congress 2018 – Exploring the importance of daily physical activity in chronic respiratory disease
Year: 2018
Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study)
Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015
Year: 2017
Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Can we change the activity behaviour of COPD patients using a telemedicine feedback intervention?
Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation
Year: 2011
Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept